Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-17T08:13:14.107Z Has data issue: false hasContentIssue false

Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells

Published online by Cambridge University Press:  02 October 2007

Y-L Yuan
Affiliation:
Department of Anatomy, Wuhan University School of Medicine, Wuhan, PR China
X-H Zhou
Affiliation:
Department of Otolaryngology–Head & Neck Surgery, Zhongnan Hospital, Wuhan University, Wuhan, PR China
Jian Song*
Affiliation:
Department of Otolaryngology–Head & Neck Surgery, Zhongnan Hospital, Wuhan University, Wuhan, PR China
X-P Qiu
Affiliation:
Medical Institute of Virus Research, Wuhan University, Wuhan, PR China
Jun Li
Affiliation:
Department of Otolaryngology–Head & Neck Surgery, Zhongnan Hospital, Wuhan University, Wuhan, PR China
L-F Ye
Affiliation:
Department of Otolaryngology–Head & Neck Surgery, Zhongnan Hospital, Wuhan University, Wuhan, PR China
*
Address for correspondence: Dr Jian Song, Department of Anatomy, Wuhan University School of Medicine, Wuhan 430071, PR China E-mail: y030612_030912_04021@126.com
Rights & Permissions [Opens in a new window]

Abstract

Objective:

The epidermal growth factor receptor (EGFR) and type 1 insulin-like growth factor receptor (type 1 IGF receptor or IGF1R) have played an important role in the growth and apoptosis of cancer. The RNA interference (RNAi) technique can suppress gene expression, but the effects of dual silencing of EGFR and type 1 IGF receptor have not been well understood.

Methods:

pU6-EGFR-shRNA-1, pU6-EGFR-shRNA-2, pU6-IGF1R-shRNA-1 and pU6-IGF-1R-shRNA-2 plasimd vectors were transfected to the nasopharyngeal cancer cells. Seven groups were selected for the study. The protein and downstream protein expression were assessed by Western blot. Apoptosis was determined via flow cytometry. Meanwhile, chemosensitivity of nasopharyngeal cancer cell lines transfeced to chemotherapeutic drugs were carried out by MTT.

Results:

In dual silencing of EGFR and IGF-1R, the protein expression much more was decreased than single silencing of EGFR or IGF-1R, but the cell apoptosis much more is increased than single silencing EGFR or IGF-1R. Dual silencing of EGFR and IGF-1R enhanced chemosensitivity to anticancer drugs, compared with single silencing of EGFR or IGF-1R.

Conclusion:

Dual silencing of EGFR and IGF-1R are capable of suppressing EGFR and IGF-1R expression of the nasopharyngeal cancer cell and can promote apoptosis and increase the cell sensitivity of anticancer drug. The dual silencing of genes RNAi technique is significantly better than a single gene.

Information

Type
Main Article
Copyright
Copyright © JLO (1984) Limited 2007
Figure 0

Fig. 1Sequences of oligonucleotides for the U6-short hairpin epidermal growth factor receptor and the U6-small hairpin (si) insulin-like growth factor I receptor. Each sequence consists of sense (19 bp), loop and antisense (19 bp) for either insulin-like growth factor I receptor or epidermal growth factor receptor. Sequences of SiRNA were started at the 380th and 3430th IGF-1R for insulin-like growth factor I receptor, and at the 349th and 643th EGFR for epidermal growth factor receptor. These deoxyribonucleic acid (DNA) strands were ligated with corresponding complimentary DNA strands.

Figure 1

Fig. 2Photomicrographs showing cells transfected with a plasmid vector containing fluorescent protein, 24 hours after transfection (EGFP ×40).

Figure 2

Fig. 3Western blot assay for insulin-like growth factor I receptor (IGF1R) and epidermal growth factor receptor (EGFR), confirming reduced expression of both proteins, compared with a negative control sample. The CNE2 nasopharyngeal cancer cells were transfected with the following U6-short hairpin ribonucleic acid segments: 3430 and 643; 380 and 349; 643; 3430; 349; 380; and negative control gene sequence (see text for details).

Figure 3

Fig. 4Flow cytometry results for CNE2 nasopharyngeal cancer cells transfected with U6-short hairpin ribonucleic acid segments. Flow cytometry showed an apoptotic peak or hypodiplod peak before the cells are resting or non-cycling (Go)/presynthesis period during synthesis of a protein initiatior of chromosome replication (G1) peak. Combinations of half U6-epidermal growth factor receptor (EGFR) 2 and half U6-insulin-like growth factor I receptor (IGF1R) 2, or of half U6-epidermal growth factor receptor 1 and half U6-insulin-like growth factor I receptor 1, showed the strongest apoptotic peaks and highest apoptosis percentages, compared with other preparations. HK = negative control gene sequence

Figure 4

Fig. 5Results for inhibition of ligand-induced phospho-Ser/Thrprotein kinase (pAkt) and phospho-extracellular signal - regulated kinase (pErk) activation by a combination of half U6-insulin-like growth factor (IGF) 1 receptor short hairpin ribonucleic acid (RNA) 2 (3430) and half U6-epidermal growth factor (EGF) receptor short hairpin RNA 2 (643). The RNA interference, mediated by sequence-specific genes for these two receptors, blocked phosphorylation of Akt and Erk in nasopharyngeal cancer cell lines, indicating that these two major anti-apoptotic pathways were inhibited. (a) is expression of EGFR and IGF-1R protein in groups one, three and seven and (b) in groups one, four and seven. Densitometric analysis shows the differences in activation for (c) Erk and (d) Akt. HK = negative control gene sequence; eIF4E = eukaryotic translation initiation factor 4E (used as internal control)

Figure 5

Fig. 6Results showing that a combination of half U6-insulin-like growth factor I receptor short hairpin ribonucleic acid (RNA) 2 (3430) and half U6-epidermal growth factor receptor short hairpin RNA 2 (643) increased the chemosensitivity of nasopharyngeal cancer cell lines. (a and b) Western blotting for caspase-3 showed that chemotherapeutic drugs reduced pro-caspase-3 (32 kDa) cleavage and induced active form (17 and 12 kDa); transfection with short hairpin RNA segments to insulin-like growth factor I receptor and to epidermal growth factor receptor enhanced the caspase cleavage in both (a) CNE2 and (b) TWO3 cell lines. (c) Tunel assay revealed that a combination of short hairpin RNA to insulin-like growth factor I receptor and to epidermal growth factor receptor improved induction of apoptosis by 5-fluorouracil (5-FU) in CNE2 cells. Blockage of insulin-like growth factor I receptor and epidermal growth factor receptor, by a combination of short hairpin RNA to insulin-like growth factor I receptor and to epidermal growth factor receptor, enhanced induction of apoptosis by cisplatin in TW03 cells more than in CNE2 cells. CDDP = cis-diamnodichloroplatinum ** = p < 0.05, compared with no-adding drug treatment (–) and dual silencing of EGF and IGF 1 receptors compared with either silencing EGF or IGF-1 receptor